About NanoVibronix, Inc. 
NanoVibronix, Inc.
Pharmaceuticals & Biotechnology
NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The Company operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The Company's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.
Company Coordinates 
Company Details
525 Executive Blvd , ELMSFORD NY : 10523-1240
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 2 Schemes (1.07%)
Foreign Institutions
Held by 3 Foreign Institutions (0.11%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Christopher Fashek
Chairman of the Board
Mr. Brian Murphy
Chief Executive Officer, Director
Dr. Harold Jacob
Chief Medical Officer, Director
DR. Martin Goldstein
Director
Michael Ferguson
Independent Director
Mr. Thomas Mika
Independent Director
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
Pharmaceuticals & Biotechnology
USD 4 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.05
-11.15%
0.11






